ClinicalTrials.Veeva

Menu

Effect of Aerobic Exercise on Biomarkers in Depression

K

Kutahya Health Sciences University

Status

Enrolling

Conditions

Major Depression

Treatments

Other: Aerobic Exercise
Other: Breathing exercise

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to investigate changes in the levels of biomarkers (IGF-1, FGF2, and EGF) involved in neuron development in patients diagnosed with major depression through the effects of breathing exercises and aerobic exercise, as well as to examine the levels of biomarkers (TNF-α, IL-6, and IL-1) and oxidative stress (TAS, TOS, MDA, and F2-isoprostane) that are thought to play a role in the pathophysiology of depression.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals who volunteer to participate in the study,
  • Between the ages of 18 and 40,
  • Have been diagnosed with clinical depression by a psychiatrist according to DSM-5 criteria

Exclusion criteria

  • Individuals with chronic conditions accompanying depression,
  • Those with walking difficulties
  • Those with respiratory system disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Exercise Group
Experimental group
Description:
Those included in the experimental group continued diaphragmatic breathing exercises every day for three weeks and walking exercises at least three days a week.
Treatment:
Other: Breathing exercise
Other: Aerobic Exercise
Control group
No Intervention group
Description:
The control group continued their routine lives, and at the end of three weeks

Trial contacts and locations

1

Loading...

Central trial contact

Hatice Solak, Assos. Prof; Vedat Kurt, Assos. Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems